QualityStocksNewsBreaks Archives - Page 11 of 1448

WednesdayOct 15, 2025 11:33 am

QualityStocksNewsBreaks – Adageis CEO Discusses AI-Driven Solutions for Value-Based Care in Latest Bell2Bell Podcast

Adageis, a healthcare technology company revolutionizing patient care through innovative digital solutions, is featured in the latest episode of The Bell2Bell Podcast, produced by IBN, a multifaceted communications organization connecting public companies with the investment community. In the interview, Adageis CEO Shane Speirs explains how the company’s AI-powered platform simplifies the administrative challenges of delivering value-based care by digitizing complex insurance and compliance processes. “We make it easy to see what measures practices need to hit and how to hit them for each individual patient,” Speirs said, noting that Adageis currently supports more than 580,000 patient lives. The conversation explores…

WednesdayOct 15, 2025 11:20 am

QualityStocksNewsBreaks – BluSky AI Inc. (OTCID: BSAI) to Present at Emerging Growth Conference on October 22, 2025

BluSky AI (OTCID: BSAI), headquartered in Salt Lake City, Utah, announced it will present at the Emerging Growth Conference on Oct. 22, 2025. The live, interactive online event will feature CEO Trent D’Ambrosio and COO Dan Gay, who will provide a corporate update and take questions from shareholders and investors. BluSky AI is developing the “Neocloud of the future” through its rapidly deployable SkyMod data centers—next-generation, scalable AI factories offering GPU-as-a-Service. To view the full press release, visit https://ibn.fm/rZT3O About BluSky AI Inc. Headquartered in Salt Lake City, Utah, BluSky AI Inc. delivers modular, rapidly deployable data center infrastructure purpose-built…

WednesdayOct 15, 2025 9:40 am

QualityStocksNewsBreaks – Alliance Creative Group, Inc. (OTC: ACGX) Expands Digital Portfolio with Acquisition of Three Industry Websites

Alliance Creative Group (OTC: ACGX) announced the acquisition of three established online platforms serving the hospitality, education, and legal sectors, marking a strategic expansion of its AI-driven digital media ecosystem. The transaction, completed through a mix of cash and restricted stock, includes a consulting agreement to align long-term interests between ACGX and the sellers. “These new acquisitions are an important part of our foundation,” said Paul Sorkin, CEO of Alliance Creative Group. “We’re acquiring established digital properties in industries with room for modernization and growth.” The acquired sites will be upgraded with enhanced technology, AI integration, and improved monetization strategies…

WednesdayOct 15, 2025 9:30 am

QualityStocksNewsBreaks – United States Antimony Corporation (NYSE American: UAMY) (NYSE Texas: UAMY) Raises $25 Million Through Securities Purchase Agreement with Leading Mutual Fund

US Antimony, a producer and processor of antimony, zeolite, and other critical minerals, announced it has entered into a securities purchase agreement with a leading long-only mutual fund for approximately $25 million in gross proceeds. The funds will support inventory expansion, additional leasehold acquisitions in Alaska and Montana, potential capacity increases at the Madero Smelter, strategic acquisitions, and general working capital. Chairman and CEO Gary C. Evans noted the Company has raised $69.25 million in three tranches over the past 45 days from two major institutions at progressively higher share prices, strengthening its institutional shareholder base. Titan Partners Group, a…

WednesdayOct 15, 2025 9:20 am

QualityStocksNewsBreaks – FAVO Capital (OTC: FAVO) Appoints Gary F. Baumann as Independent Director

FAVO Capital (OTC: FAVO), a diversified financial company with operations in financial services and real estate, announced the appointment of Gary F. Baumann, Esq., as an independent director to its board. A founding partner of Baumann, Gant, Keeley & Biondi, P.A., Baumann brings over 25 years of experience in construction and commercial litigation, having tried more than 70 civil jury cases and advised developers and institutions on compliance and risk management. “Gary’s appointment reflects our ongoing commitment to building a board with the independence, experience, and perspective needed to guide FAVO’s next phase of growth,” said Shaun Quin, President of FAVO…

WednesdayOct 15, 2025 9:10 am

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Submits Notice of Operations to BLM for Drilling at West Santa Fe Project

This article has been disseminated on behalf of Lahontan Gold and may include a paid advertisement. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced it has submitted a Notice of Operations to the U.S. Bureau of Land Management for its planned exploration drilling program at the West Santa Fe Project, located 13 kilometers southwest of the Company’s flagship Santa Fe Mine Project. The Notice covers multiple drill sites, access roads, and drilling sumps as Lahontan prepares to twin historic holes, drill down-dip, and test mineralization along strike. Historical work totaling 171 drill holes over 13,000 meters outlined shallow, oxidized gold and silver…

WednesdayOct 15, 2025 9:00 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Signs LOI to Acquire NYIAX, Expanding Blockchain and Exchange Capabilities Across Global Markets

Datavault AI (NASDAQ: DVLT), a pioneer in AI-driven data valuation, monetization, and acoustic technologies, announced it has signed a letter of intent to acquire NYIAX Inc., a technology and services company with operations in the U.S., Europe, and Dubai. The proposed acquisition, subject to Nasdaq approval and execution of a definitive agreement, would integrate NYIAX’s blockchain-powered exchange, patent portfolio, marketing-as-a-service agency, and advertising unit into Datavault AI’s expanding ecosystem. The deal builds on an existing licensing partnership for Datavault AI’s ADIO(R) ultrasonic technology and will enhance its patented Information Data Exchange(R) (IDE) platform by adding transparent, automated trading capabilities. Datavault…

TuesdayOct 14, 2025 3:41 pm

QualityStocksNewsBreaks – RADR(R) Platform Powers Lantern Pharma Inc.’s (NASDAQ: LTRN) Push Into Rare Pediatric Brain Cancer Treatment

Lantern Pharma (NASDAQ: LTRN) is developing a number of clinical trials, using its proprietary drug candidates and computational biology and machine learning platform, to target conditions with unmet medical needs. The company was featured in a recent article that discussed its preparation for the launch of a trial targeting a rare pediatric disease, planned for Q1 2026. This comes “in the wake of its optimistic meeting with the U.S. Food and Drug Administration (‘FDA’) to receive critical guidance on the company’s trial design and the FDA’s regulatory pathway… Lantern Pharma is developing its clinical trial with the hope of demonstrating the…

TuesdayOct 14, 2025 3:00 pm

QualityStocksNewsBreaks – New Patent Strengthens Wearable Devices Ltd.’s (NASDAQ: WLDS) IP in Neural Interfaces for XR, Industry, Assistive Tech

Wearable Devices (NASDAQ: WLDS, WLDSW) was granted a new U.S. patent that protects groundbreaking neural interface technology that measures weight, torque, and force directly from wrist-based sensors with applications spanning XR, industrial automation, and assistive technology. This was featured in a recent article that reads, “The patent encompasses voice-controlled interfaces and innovations in brain-computer interfaces, strengthening the company’s intellectual property position in the rapidly expanding $260 billion AI wearables market… WLDS’s newly granted patent titled ‘Gesture and Voice-Controlled Interface Device’ represents significant advancement in neural interface intellectual property. Unlike typical gesture patents focused on movement recognition, this protection covers neural measurement…

TuesdayOct 14, 2025 2:20 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Updates U.S. Medical Advisory Board to Advance Phase 3 Development of HyBryte for CTCL

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on treatments for rare diseases, announced updates to its U.S. Medical Advisory Board for cutaneous T-cell lymphoma (CTCL) to support the ongoing Phase 3 development of HyBryte(TM) (synthetic hypericin). The board, comprised of leading dermatologic and oncologic experts, will provide strategic guidance as Soligenix advances regulatory and commercialization activities for its photodynamic therapy. President and CEO Christopher J. Schaber, PhD, said the addition of new key opinion leaders reinforces the program’s clinical depth and the company’s commitment to bringing HyBryte to CTCL patients worldwide. To view the full press release, visit https://ibn.fm/9LzBI…

Site Search

Company Search

Category: QualityStocksNewsBreaks